AMICUS THERAPEUTICS, INC.
FOLD · NASDAQ
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.
Market Data
Price
$14.36
-0.01 (-0.07%)
Market Cap$4.51B
P/E Ratio—
EPS$—
52W High$14.38
52W Low$5.51
Beta0.50
Data from Finnhub · Updated Mar 11, 2026